<ENAMEX TYPE="ORGANIZATION">International Power Machines Corp.</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Smith Laboratories Inc.</ENAMEX> scrapped plans to merge in the face of stockholder resistance.
A spokesman for <ENAMEX TYPE="ORGANIZATION">International Power</ENAMEX> said no reason for the cancellation of the agreement would be disclosed because such information is ``not vital public information.''
However, earlier this month, a large, individual stockholder in <ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX>, <ENAMEX TYPE="PERSON">Joel Rocha Garza</ENAMEX>, said he would seek to block the proposed transaction. As of Sept. 8, Mr. <ENAMEX TYPE="PERSON">Garza</ENAMEX> and his company, <ENAMEX TYPE="ORGANIZATION">Clarendon Group Ltd.</ENAMEX>, had an 8.46% stake in <ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX>.
<ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX> is a <ENAMEX TYPE="LOCATION">San Diego</ENAMEX> drug maker. <ENAMEX TYPE="ORGANIZATION">International Power Machines</ENAMEX> is a <ENAMEX TYPE="LOCATION">Garland</ENAMEX>, <ENAMEX TYPE="LOCATION">Texas</ENAMEX>, maker of uninterruptible power systems.
